pocketful logo
Adline Chem Lab Ltd logo

Adline Chem Lab Ltd

NSE: BSE: 524604

₹14.02

(-4.95%)

Sun, 08 Mar 2026, 07:31 pm

Adline Chem Lab Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    7.79

  • Net Profit

    -0.13

  • P/B

    -5.20

  • Sector P/E

    40.49

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.89

  • ROCE (Industry)

    16.43

  • RONW (Industry)

    14.36

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0

  • EPS (TTM)

    0.04

  • Dividend Yield

    0

  • Book Value

    -2.76

  • Interest Cover

    -0.25

Analysis

all

thumbs up icon

Pros

  • Kamron Laboratories has no debt, it does not need to be covered by operating cash flow.
  • Kamron Laboratories has no debt, it does not need to be covered by short term assets.
  • Kamron Laboratories has not taken on any debt in the past 5 years.
  • Kamron Laboratories has no debt, therefore coverage of interest payments is not a concern.
  • Kamron Laboratories has no debt.
thumbs up icon

Cons

  • Unable to evaluate Kamron Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Kamron Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Kamron Laboratories is not covered by any analysts.
  • BSE:524604 has not traded for 39 days.
  • BSE:524604 is flat (0%) underperforming the Pharmaceuticals industry which returned 6.8% over the past month.

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters25.8529.6129.6129.6129.61
FII00000
DII00000
Public74.1570.3970.3970.3970.39
Government00000

Read More

Technical Analysis

RSI

-

MACD

-

50 DMA

-

200 DMA

-

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic-------
Fibonacci-------
Camarilla-------

Pivots Level: Classic

R3

+-

-

R2

+-

-

R1

+-

-

-
-
Pivot Point
LTP: -

S1

--

-

S2

--

-

S3

--

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    -

  • 20-EMA

    -

  • 30-EMA

    -

  • 50-EMA

    -

  • 100-EMA

    -

  • 200-EMA

    -

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
10 Feb 2026board-meetingsQuarterly Results, Change in Directors
13 Jun 2025agm
11 Dec 2024egm
24 Aug 2024agm
18 Jul 2023agm
01 Aug 2022agm
26 Jul 2021agm

Read More

Peer Comparison

No Result Found

Adline Chem Lab Ltd logo

Adline Chem Lab Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Read More

Adline Chem Lab Ltd About

Adline Chem Lab is primarily engaged ir. the business of manufacturing of pharmaceutical chemicals, fine chemicals, agrochemicals products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1988

Headquarters

CEO

Vrushank Balkrushna Patel

Employees

Contact

Website icon

Website

http://www.kamronlabs.com

Email icon

Email

info@kamronlabs.com

Phone icon

Phone

Location icon

Location

A-514 Steller Opp Arista Bldg, Sindhu bhavan Road Bodakdev, Ahmedabad, Gujarat, 380054

Read More

Adline Chem Lab Ltd Company History

YearHistory
1988
  • The company was incorporated as a private limited company.
1989
  • The company became a public limited company.
2022
  • The company name was changed to Adline Chem Lab Ltd.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
No Result Found

Read More

Adline Chem Lab Ltd News

Adline Chem Lab Appoints New Chairman & MD

Adline Chem Lab Limited's board approves appointment of Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for five years, effective February 10, 2026, subject to shareholder approval.

10 Feb 2026

stocks

Adline Chem Lab Receives BSE Approval for Promoter Reclassification, Gets Warning for Disclosure Delay

Adline Chem Lab Limited received BSE approval to reclassify 12 promoter shareholders to public category, reducing promoter holding from 29.61% to 25.86% and increasing public holding to 74.14%. BSE issued a warning letter to the company for delayed disclosure of the reclassification application, submitted on February 7, 2025 but disclosed on February 10, 2025, violating the 24-hour disclosure requirement.

26 Nov 2025

corporate action

Adline Chem Lab Reports Leadership Changes and Quarterly Results

Adline Chem Lab Limited announced significant board changes during its November 12, 2025 meeting. Sarang Pathak resigned from his position as Executive Director-Chairman (Managing Director) and Hemant Parikh stepped down as Non-Executive Promoter Director, both effective from the close of business on November 12, 2025. The company appointed Vrushank Patel as the new Chairman of the Board and authorized him to handle necessary documentation and approvals. The board also approved unaudited standalone financial results for the quarter and half-year ended September 30, 2025, along with noting the statutory auditors' limited review report. The company's cash and cash equivalents increased to 7.36 from 6.32 in the previous period, while it reported a loss before tax of 13.89 for the half-year period.

12 Nov 2025

corporate governance

Adline Chem Lab Limited's Company Secretary Akshita Khandelwal Resigns Due to Personal Reasons

Akshita Khandelwal has resigned from her position as Company Secretary, Compliance Officer, and Key Managerial Personnel of Adline Chem Lab Limited, effective from the close of business on August 14, 2025. The resignation was attributed to personal and unavoidable reasons, with no other material reasons cited for her departure. The company has informed the stock exchange of this change in key personnel as required under regulatory obligations.

14 Aug 2025

corporate governance

Adline Chem Lab Limited Approves Quarterly Financial Results for Quarter Ended June 30, 2025

Adline Chem Lab Limited's Board of Directors approved the unaudited standalone financial results for the quarter ended June 30, 2025, during a meeting held on August 12, 2025. The board noted the Limited Review Report from statutory auditors, which contained no qualifications or modifications. The company also acknowledged a SEBI circular regarding a special window for re-lodgement of transfer requests for physical shares under the Ease of Doing Investments initiative. The financial results were prepared in accordance with Indian Accounting Standards and were reviewed and recommended by the audit committee.

12 Aug 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800